No Data
No Data
Macquarie Group Reduces Stake in Alpha HPA
Macquarie Group Adjusts Stake in Alpha HPA
Targeted Alpha Therapy Market Size, Drugs Approval, Proprietary Technologies & Clinical Trials Insight to 2028 - ResearchAndMarkets.com
Puma Alpha VCT PLC Updates Share Capital and Voting Rights
Alpha Tau to Present Groundbreaking Cancer Therapy Data at ASCO Symposium
Alpha Tau Announces Upcoming Presentation Of An Abstract Entitled "Interim Analysis Of Feasibility, Safety, And Tumor Control In Two First-In-Human Trials Of A Novel Alpha-Emitting Radionuclide For Pancreatic Adenocarcinoma" At 2025 ASCO GI Symposium...